HH Biotechnology Holdings Company (HHBT)
HH Biotechnology Holdings Company operates in the Real Estate - Services industry of the Real Estate sector, headquartered in Shenyang, LI, CN. The stock last traded at $0.00, up 0.00% on the session, giving a market capitalisation of $1,406. On trailing twelve-month figures it carries a trailing P/E of 0.00, a net margin of 31.0%. Its beta of 3.92 implies it has historically moved more than the broad market.
HH Biotechnology Holdings Company operates within the health and green industries. Its primary activities include the cultivation and distribution of macadamia nuts, which are then utilized in a broad spectrum of products, including foodstuffs, culinary oils, wellness items, personal care products, and cosmetic formulations. The entity, originally established in 1987, was previously named Great China International Holdings, Inc. before rebranding to HH Biotechnology Holdings Company in August 2016. Its corporate headquarters are situated in Shenyang, People's Republic of China.
HH Biotechnology Holdings Company is most often compared with the following Real Estate names: